Sign in to fuzzto save your conversations, follow your research and come back anytime.
Glenmark Pharmaceuticals
GLENMARK
NSE
BSE
NSEBSESectorHealthcare
2,459.00
Loading chart…
About the company
Glenmark Pharmaceuticals Ltd is an Indian research-led global pharmaceutical company founded in 1977. It focuses on developing and manufacturing branded generics, generic drugs, and over-the-counter products in therapeutic areas like respiratory, dermatology, and oncology. The company has a significant presence in emerging markets and operates 14 manufacturing facilities across several countries. Glenmark is involved in drug discovery for new chemical and biological entities, with molecules in various stages of development. It has a strong generics business serving markets like the US and Europe, and an active pharmaceutical ingredients business selling to over 80 countries. The company has made several acquisitions and licensing deals to expand its product portfolio and global reach. Glenmark has launched numerous products across various therapeutic segments and markets, including innovative combinations and first-to-market generics. It has a substantial pipeline of ANDAs filed with the US FDA and continues to receive approvals for new generic products.
In the news
90+ Companies Go Ex-Dividend This Week: NTPC, Coal India Lead
Sensex jumps 524 pts; media shares surge 1.62%
Glenmark expands US portfolio with Calcium Gluconate launch
Glenmark Pharma Maintains Buy Rating with ₹2,570 Target
Brokerages Turn Positive on Glenmark, United Spirits, Kansai Nerolac
India's Pharma Renaissance: From Generics to Drug Discovery
Glenmark gets USFDA nod for expanded pediatric RYALTRIS use
Pharma stocks surge 2% on defensive buying amid market weakness
5 Stocks to Buy: Adani Power, Glenmark, Tata Steel & More
Glenmark Pharma rises 2.24% for third straight session
Glenmark advances Trastuzumab rezetecan to Phase 3 trials
Glenmark Pharma gets 6 FDA observations after Goa plant inspection
Glenmark launches Methylene Blue Injection in US market
Glenmark launches Winlevi acne treatment across European markets
Glenmark Pharma profit expected to soar 5x in 2 years: Motilal Oswal
Sensex Falls 117 Points After RBI Policy; Infrastructure Stocks Hit
IEX, Glenmark, Titan: 3 F&O stocks for short-term trading
Religare Broking picks Glenmark, JSW Energy, Marico for short term
Glenmark gets USFDA approval for progesterone inserts
Trump's Pharma Tariffs: Indian Drugmakers Face Divergent Risks